Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ondansetron HCL I.P. 8mg
Therapeutic Category
Gastroenterology
Dosage Form
Injection
Packaging Type
vial
Packaging
5x1ml
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Ondotyle 8 is a highly effective injectable formulation containing Ondansetron Hydrochloride I.P. at a concentration of 8 mg per injection. Ondansetron is a selective serotonin 5-HT3 receptor antagonist that is primarily used to prevent nausea and vomiting associated with chemotherapy, radiation therapy, and postoperative recovery. By blocking the action of serotonin, a neurotransmitter that can trigger nausea and vomiting, Ondotyle 8 provides rapid relief for patients undergoing treatments that may induce these distressing symptoms.
Common side effects may include headache, dizziness, constipation, and fatigue. Rarely, allergic reactions or changes in heart rhythm may occur, requiring immediate medical attention.
Ondotyle 8 is indicated for the prevention and treatment of nausea and vomiting associated with chemotherapy, radiation therapy, and postoperative recovery.
Administer only under the supervision of a qualified healthcare professional. Not recommended for patients with known hypersensitivity to Ondansetron or other 5-HT3 antagonists.
Store below 25°C. Protect from light. Do not freeze. Keep out of reach of children.
Composition : Ondansetron (8 mg) MD
Composition : Ondansetron (2mg)
Composition : Ondansetron (4mg) MD
Composition : Ondansetron (2mg) + Ranitidine (25mg)
Composition : Dicyclomine (10mg) + Ranitidine (150mg) + Simethicone (20mg)
Composition : Ranitidine (75mg/5ml)
Composition : Ondansetron (4mg) + Rabeprazole (20mg)
Composition : Levosulpiride (75mg) + Rabeprazole (20mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Ondansetron HCl 8 mg Injection is a high-demand product in the general medicine, gastroenterology, oncology, surgical care, and hospital segment, making it a valuable addition to a PCD pharma franchise portfolio. With its widespread use in hospitals, nursing homes, emergency care settings, and specialty clinics, Ondansetron Injection enjoys consistent demand from physicians, surgeons, anesthetists, oncologists, and healthcare institutions across India.
Medical distributors and franchise partners can benefit from the strong demand for antiemetic therapies. Commonly prescribed for the prevention and management of nausea and vomiting under medical supervision Frequently used in surgical, oncology, and gastroenterology settings Widely recommended by physicians, anesthetists, and healthcare professionals Strong demand across hospitals, emergency departments, and specialty clinics Injectable formulation is suitable for institutional and critical care use Essential product in hospital and acute care portfolios This strengthens a comprehensive hospital care and gastroenterology product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ondansetron HCl 8 mg Injection with exclusive monopoly rights, promotional support, attractive packaging, and competitive pricing for distributors, stockists, and wholesalers across India.
Wholesalers and medical agencies can benefit from: Strong hospital and institutional demand Consistent prescription usage across multiple specialties High market acceptance among healthcare professionals Reliable product availability and supply chain support Attractive business margins and long-term growth opportunities Strong repeat-order potential from hospitals and clinics These advantages contribute to sustainable sales growth and business expansion.
Interested distributors, stockists, and pharma entrepreneurs can partner with Cafoli LifeCare Pvt Ltd to access profitable PCD pharma franchise opportunities for Ondansetron HCl 8 mg Injection. With exclusive monopoly rights, comprehensive promotional support, quality-assured formulations, attractive profit margins, and dependable logistics services, Cafoli LifeCare Pvt Ltd helps franchise partners establish and expand a successful pharmaceutical business across India.